Supernus Pharmaceuticals | SUPN - Ebit





Ebit Veränderung Datum
Abbott USD 2.13B 281M 2026-06
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Aurora Cannabis CAD 7.12M 42.91M 2026-03
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Canopy Growth CAD -145.65M 132.99M 2026-03
Cara Therapeutics USD -7.05M 1.11M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Novo Nordisk DKK 33.76B 25.86B 2026-06
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Xeris Pharmaceuticals USD 9.12M 7.65M 2026-03